0001140361-24-009271.txt : 20240223
0001140361-24-009271.hdr.sgml : 20240223
20240223163735
ACCESSION NUMBER: 0001140361-24-009271
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240221
FILED AS OF DATE: 20240223
DATE AS OF CHANGE: 20240223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harris Theodore L
CENTRAL INDEX KEY: 0001378228
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13648
FILM NUMBER: 24672022
MAIL ADDRESS:
STREET 1: 5200 BLAZER PARKWAY
CITY: DUBLIN
STATE: OH
ZIP: 43017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BALCHEM CORP
CENTRAL INDEX KEY: 0000009326
STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 132578432
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 PARAGON DRIVE
CITY: MONTVALE
STATE: NJ
ZIP: 07645
BUSINESS PHONE: (845) 326-5600
MAIL ADDRESS:
STREET 1: 5 PARAGON DRIVE
CITY: MONTVALE
STATE: NJ
ZIP: 07645
4
1
form4.xml
X0508
4
2024-02-21
0000009326
BALCHEM CORP
BCPC
0001378228
Harris Theodore L
C/O BALCHEM CORPORATION
5 PARAGON DRIVE
MONTVALE
NJ
07645
true
true
Chairman, President & CEO
false
Common Stock
2024-02-21
4
S
0
10797
152.9738
D
85294
D
Common Stock
2024-02-21
4
S
0
16015
153.7461
D
69279
D
Common Stock
2024-02-21
4
S
0
2667
154.8359
D
66612
D
Common Stock
2024-02-21
4
S
0
200
155.91
D
66412
D
Common Stock
2024-02-22
4
M
0
10000
54.87
A
76412
D
Common Stock
2024-02-22
4
M
0
24350
60.85
A
100762
D
Common Stock
2024-02-22
4
S
0
14497
153.5564
D
86265
D
Common Stock
2024-02-22
4
S
0
13989
154.66
D
72276
D
Common Stock
2024-02-22
4
S
0
5864
155.249
D
66412
D
Stock Options (right to buy)
54.87
2024-02-22
4
M
0
10000
0
A
2025-04-28
Common Stock
10000
0
D
Stock Options (right to buy)
60.85
2024-02-22
4
M
0
24350
0
A
2026-02-23
Common Stock
24350
0
D
This transaction was executed in multiples sales ranging from $152.3350 to $153.3200 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
This transaction was executed in multiples sales ranging from $153.3400 to $154.2900 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
This transaction was executed in multiples sales ranging from $154.4700 to $155.3800 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
Exercise of fully vested non-qualified stock options.
This transaction was executed in multiple sales ranging from $153.0800 to $154.0775 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
This transaction was executed in multiple sales ranging from $154.0800 to $155.0750 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
This transaction was executed in multiple sales ranging from $155.0800 to $155.5700 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
Stock options that vested 20% on April 28, 2016, 40% on April 28, 2017, and 40% on April 28, 2018, and are exercisable.
Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable.
/s/ Travis Larsen, Attorney in Fact for Theodore L. Harris
2024-02-23